Shanghai Kehua Bio-Engineering Co Ltd (002022) — Cash Flow-to-Debt Ratio
Shanghai Kehua Bio-Engineering Co Ltd (002022) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥28.25 Million could theoretically repay 0% of its total liabilities (CN¥1.47 Billion) in one year. See 002022 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Kehua Bio-Engineering Co Ltd Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for Shanghai Kehua Bio-Engineering Co Ltd across 24 annual periods. Also explore Shanghai Kehua Bio-Engineering Co Ltd (002022) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shanghai Kehua Bio-Engineering Co Ltd (2002–2025)
Year-by-year debt coverage analysis for Shanghai Kehua Bio-Engineering Co Ltd. For market capitalisation and broader financial context, see market value of Shanghai Kehua Bio-Engineering Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | CN¥22.44 Million | CN¥1.53 Billion | ▲ +136.6% |
| 2024 | -0.04x | CN¥-50.12 Million | CN¥1.25 Billion | ▲ +84.7% |
| 2023 | -0.26x | CN¥-474.89 Million | CN¥1.82 Billion | ▼ -135.8% |
| 2022 | 0.73x | CN¥2.15 Billion | CN¥2.96 Billion | ▲ +22.9% |
| 2021 | 0.59x | CN¥1.08 Billion | CN¥1.82 Billion | ▼ -10.1% |
| 2020 | 0.66x | CN¥1.37 Billion | CN¥2.08 Billion | ▲ +168.1% |
| 2019 | 0.25x | CN¥248.87 Million | CN¥1.01 Billion | ▲ +107.8% |
| 2018 | 0.12x | CN¥126.79 Million | CN¥1.07 Billion | ▼ -42.5% |
| 2017 | 0.21x | CN¥130.71 Million | CN¥636.48 Million | ▼ -69.2% |
| 2016 | 0.67x | CN¥281.25 Million | CN¥422.47 Million | ▲ +2.7% |
| 2015 | 0.65x | CN¥224.30 Million | CN¥345.97 Million | ▼ -58.1% |
| 2014 | 1.55x | CN¥249.64 Million | CN¥161.39 Million | ▲ +0.2% |
| 2013 | 1.54x | CN¥250.22 Million | CN¥162.08 Million | ▲ +43.8% |
| 2012 | 1.07x | CN¥213.74 Million | CN¥199.05 Million | ▼ -14.1% |
| 2011 | 1.25x | CN¥219.80 Million | CN¥175.89 Million | ▼ -19.6% |
| 2010 | 1.55x | CN¥241.83 Million | CN¥155.58 Million | ▼ -4.9% |
| 2009 | 1.64x | CN¥217.51 Million | CN¥133.03 Million | ▲ +11.1% |
| 2008 | 1.47x | CN¥137.66 Million | CN¥93.56 Million | ▲ +64.4% |
| 2007 | 0.90x | CN¥112.93 Million | CN¥126.16 Million | ▼ -11.3% |
| 2006 | 1.01x | CN¥87.21 Million | CN¥86.46 Million | ▲ +4.1% |
| 2005 | 0.97x | CN¥73.97 Million | CN¥76.32 Million | ▲ +26.3% |
| 2004 | 0.77x | CN¥48.74 Million | CN¥63.51 Million | ▼ -10.5% |
| 2003 | 0.86x | CN¥70.57 Million | CN¥82.31 Million | ▲ +63.9% |
| 2002 | 0.52x | CN¥41.48 Million | CN¥79.29 Million | — |